Was FDA Lax in Approving Opioids Too Easily?
By Dennis Thompson HealthDay Reporter WEDNESDAY, Sept. 30, 2020 (HealthDay News) — For at least two decades, the U.S. Food and Drug Administration has been approving new formulations of prescription opioids without requiring drug manufacturers to gather important information on safety and effectiveness, a new study claims. The FDA approved dozens of these highly addictive … Read more